126 related articles for article (PubMed ID: 38447349)
1. Nonalcoholic Fatty Liver Disease, Bone and Muscle Quality in Prolactinoma: A Pilot Study.
Eroğlu İ; Iremli BG; Erkoc A; Idilman IS; Yuce D; Kutukcu EC; Akata D; Erbas T
J Clin Densitom; 2024; 27(2):101479. PubMed ID: 38447349
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcopenia in acromegaly: reduced muscle quality and increased vertebral fat deposition.
Eroğlu I; İremli BG; Erkoç A; Idilman IS; Yuce D; Calik-Kutukcu E; Akata D; Erbas T
J Endocrinol Invest; 2023 Dec; 46(12):2573-2582. PubMed ID: 37212954
[TBL] [Abstract][Full Text] [Related]
3. Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction-associated steatotic liver disease.
Kumada T; Toyoda H; Ogawa S; Gotoh T; Suzuki Y; Sugimoto K; Yoshida Y; Kuroda H; Kamada Y; Sumida Y; Ito T; Akita T; Tanaka J
Liver Int; 2024 Jul; 44(7):1700-1714. PubMed ID: 38558221
[TBL] [Abstract][Full Text] [Related]
4. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
Chen J; Allen AM; Therneau TM; Chen J; Li J; Hoodeshenas S; Chen J; Lu X; Zhu Z; Venkatesh SK; Song B; Ehman RL; Yin M
Eur Radiol; 2022 Feb; 32(2):950-958. PubMed ID: 34432123
[TBL] [Abstract][Full Text] [Related]
5. MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial).
Ajmera VH; Cachay E; Ramers C; Vodkin I; Bassirian S; Singh S; Mangla N; Bettencourt R; Aldous JL; Park D; Lee D; Blanchard J; Mamidipalli A; Boehringer A; Aslam S; Leinhard OD; Richards L; Sirlin C; Loomba R
Hepatology; 2019 Nov; 70(5):1531-1545. PubMed ID: 31013363
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Utility of Noninvasive Scores in Patients With Acromegaly.
Eroğlu İ; Iremli BG; Idilman IS; Yuce D; Lay I; Akata D; Erbas T
J Clin Endocrinol Metab; 2023 Dec; 109(1):e119-e129. PubMed ID: 37590020
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome.
Çelik Eroğlu B; Karaçoban L; Idılman IS; Korkusuz F; Yıldız BO
Maturitas; 2024 Jul; 185():107982. PubMed ID: 38579578
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease.
Choi SJ; Kim SM; Kim YS; Kwon OS; Shin SK; Kim KK; Lee K; Park IB; Choi CS; Chung DH; Jung J; Paek M; Lee DH
Diabetes Metab J; 2021 Sep; 45(5):739-752. PubMed ID: 33108854
[TBL] [Abstract][Full Text] [Related]
10. Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
Fowler KJ; Venkatesh SK; Obuchowski N; Middleton MS; Chen J; Pepin K; Magnuson J; Brown KJ; Batakis D; Henderson WC; Shankar SS; Kamphaus TN; Pasek A; Calle RA; Sanyal AJ; Loomba R; Ehman R; Samir AE; Sirlin CB; Sherlock SP
Radiology; 2023 Oct; 309(1):e231092. PubMed ID: 37815451
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Steatosis is Negatively Associated with Bone Mineral Density in Children.
Chun LF; Yu EL; Sawh MC; Bross C; Nichols J; Polgreen L; Knott C; Schlein A; Sirlin CB; Middleton MS; Kado DM; Schwimmer JB
J Pediatr; 2021 Jun; 233():105-111.e3. PubMed ID: 33545191
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Quantitative Imaging Biomarkers for Early-phase Clinical Trials of Steatohepatitis in Adolescents.
Goyal NP; Sawh MC; Ugalde-Nicalo P; Angeles JE; Proudfoot JA; Newton KP; Middleton MS; Sirlin CB; Schwimmer JB
J Pediatr Gastroenterol Nutr; 2020 Jan; 70(1):99-105. PubMed ID: 31633654
[TBL] [Abstract][Full Text] [Related]
15. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
[TBL] [Abstract][Full Text] [Related]
16. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R
Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123
[TBL] [Abstract][Full Text] [Related]
17. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
[TBL] [Abstract][Full Text] [Related]
18. Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
Kumada T; Toyoda H; Yasuda S; Ogawa S; Gotoh T; Ito T; Tada T; Tanaka J
AJR Am J Roentgenol; 2022 Oct; 219(4):604-612. PubMed ID: 35506556
[No Abstract] [Full Text] [Related]
19. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]